BCATc Inhibitor 2 is primarily used in biochemical research to study the role of branched-chain amino acid transaminase 1 (BCAT1) in cellular processes. It is particularly valuable in investigating metabolic pathways, especially those involving amino acid metabolism, and its impact on cancer cell proliferation and survival. Researchers utilize this inhibitor to explore its potential in targeting cancer cells that rely on altered amino acid metabolism for growth. Additionally, it aids in understanding the relationship between BCAT1 activity and neurological disorders, providing insights into therapeutic strategies for conditions like glioblastoma and other diseases linked to metabolic dysregulation.